Suicide attempt and severe depression in a patient with COVID-19, the possible effect of therapeutic regimes

IF 0.2 Q4 PSYCHIATRY
Vahid Reisi-Vanani, Maryam Keihani
{"title":"Suicide attempt and severe depression in a patient with COVID-19, the possible effect of therapeutic regimes","authors":"Vahid Reisi-Vanani, Maryam Keihani","doi":"10.23736/s2724-6612.21.02199-0","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) has different manifestations including neurologic manifestations. Lack of a suit-able therapeutic regime and administration of a variety of treatments could worsen disease manifestations. Some medical interventions besides the high level of stress and quarantined conditions could induce severe depression and even suicide attempts. Here we presented a 42-year-old man without a history of psychiatric disorders that had been admitted to the clinic due to worsening of his dyspnea. After history taking and physical examination, he had been hospitalized and interferon, corticosteroids, and other conservative treatments had been started. According to his clinical manifestations, the doses and medications had been changed the next days. On the morning of his seventh day of hospitalization he had several suicidal attempts which were not successful and after changes in his medications, starting antidepressant drugs, and visiting his family members he had been discharged without the idea of suicide and depressed mood. This report showed the important role of medical staff in monitoring the mental health of COVID-19 patients as there are many risk factors for them to develop psychiatric disturbance. They should be aware of the possible effect of drugs in the alternat-ing mood of patients and even causing suicidal thoughts. We also suggest increasing the level of tryptophan sources in meals of patients and administration of selective serotonin reuptake inhibitors in patients with signs of depression after further studies.","PeriodicalId":29829,"journal":{"name":"Minerva Psychiatry","volume":"13 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s2724-6612.21.02199-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Coronavirus disease 2019 (COVID-19) has different manifestations including neurologic manifestations. Lack of a suit-able therapeutic regime and administration of a variety of treatments could worsen disease manifestations. Some medical interventions besides the high level of stress and quarantined conditions could induce severe depression and even suicide attempts. Here we presented a 42-year-old man without a history of psychiatric disorders that had been admitted to the clinic due to worsening of his dyspnea. After history taking and physical examination, he had been hospitalized and interferon, corticosteroids, and other conservative treatments had been started. According to his clinical manifestations, the doses and medications had been changed the next days. On the morning of his seventh day of hospitalization he had several suicidal attempts which were not successful and after changes in his medications, starting antidepressant drugs, and visiting his family members he had been discharged without the idea of suicide and depressed mood. This report showed the important role of medical staff in monitoring the mental health of COVID-19 patients as there are many risk factors for them to develop psychiatric disturbance. They should be aware of the possible effect of drugs in the alternat-ing mood of patients and even causing suicidal thoughts. We also suggest increasing the level of tryptophan sources in meals of patients and administration of selective serotonin reuptake inhibitors in patients with signs of depression after further studies.
COVID-19患者的自杀企图和严重抑郁症,治疗方案的可能影响
冠状病毒病2019 (COVID-19)具有不同的表现,包括神经系统表现。缺乏合适的治疗方案和多种治疗方法可能使疾病表现恶化。除了高水平的压力和隔离条件外,一些医疗干预措施可能会导致严重的抑郁甚至自杀企图。在这里,我们提出了一个42岁的男子,没有精神疾病的历史,已入院的诊所,由于他的呼吸困难的恶化。经病史和体格检查,住院治疗,并给予干扰素、皮质激素等保守治疗。根据他的临床表现,在接下来的几天里,剂量和药物已经改变了。在住院第7天的早晨,他有几次自杀企图,但都没有成功,在改变了他的药物,开始服用抗抑郁药物,并拜访了他的家人后,他出院了,没有自杀的想法和抑郁情绪。该报告显示了医务人员在监测COVID-19患者心理健康方面的重要作用,因为他们发生精神障碍的危险因素很多。他们应该意识到药物在患者情绪变化中可能产生的影响,甚至引起自杀念头。我们还建议在进一步的研究后,增加患者膳食中色氨酸来源的水平,并在有抑郁症状的患者中使用选择性血清素再摄取抑制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Minerva Psychiatry
Minerva Psychiatry PSYCHIATRY-
CiteScore
0.70
自引率
0.00%
发文量
48
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信